Christopher Frenz, AVP of Information Security, Interfaith Medical Center During the past few months, much has been said about the significant effort required to implement and support virtual care and remote work. But for IT security leaders, that big lift comes with a big risk. As clinical and non-clinical functions are increasingly performed outside of… Read More »
If you have ever tried losing weight, you know it can be very challenging. Everyone experiences challenges that are specific to their unique circumstances. These range from a lack of time, to genetics, stress, and unmet expectations from trying more than once. Most people can encounter these roadblocks, but that does not mean that they… Read More »
Pfizer hit some unexpected roadblocks with its first U.S. biosimilar launch, but it’s not giving up in the budding field. Now, the drugmaker is launching biosims to three Roche cancer blockbusters at discounts ranging from 22% to 24%. The company has already rolled out Zirabev and Ruxience, its biosimilars to Roche’s Avastin and Rituxan, respectively, at discounts of 23% and 24%. On… Read More »